R. STAHL AG (FRA:RSL2)

Intra-Cellular Therapies Revenue

R. STAHL AG had revenue of 74.39M EUR in the quarter ending March 31, 2025, a decrease of -13.17%. This brings the company's revenue in the last twelve months to 336.73M, down -1.28% year-over-year. In the year 2024, R. STAHL AG had annual revenue of 348.01M with 4.00% growth.

• Revenue (ttm): 336.73M
• Revenue Growth: -1.28%
• P/S Ratio: 0.34
• Revenue / Employee: 194.42K
• Employees: 1,862
• Market Cap: 113.99M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	348.01M	13.38M	4.00%
Dec 31, 2023	334.63M	55.26M	19.78%
Dec 31, 2022	279.37M	25.78M	10.17%
Dec 31, 2021	253.59M	2.53M	1.01%
Dec 31, 2020	251.07M	-27.78M	-9.96%